Skip to main content
PMC home page
Protein & Cell logoLink to Protein & Cell
. 2012 Nov 17;3(12):934–942. doi: 10.1007/s13238-012-2107-5

Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis

Sheng-Lian Yang 1, Erica Harnish 2, Thomas Leeuw 3, Uwe Dietz 3, Erika Batchelder 1, Paul S Wright 2, Jane Peppard 2, Paul August 2, Cecile Volle-Challier 4, Francoise Bono 4, Jean-Marc Herbert 4, Juan Carlos Izpisua Belmonte 1,5,✉
PMCID: PMC4875386  PMID: 23161332

Abstract

Articular cartilage, which is mainly composed of collagen II, enables smooth skeletal movement. Degeneration of collagen II can be caused by various events, such as injury, but degeneration especially increases over the course of normal aging. Unfortunately, the body does not fully repair itself from this type of degeneration, resulting in impaired movement. Microfracture, an articular cartilage repair surgical technique, has been commonly used in the clinic to induce the repair of tissue at damage sites. Mesenchymal stem cells (MSC) have also been used as cell therapy to repair degenerated cartilage. However, the therapeutic outcomes of all these techniques vary in different patients depending on their age, health, lesion size and the extent of damage to the cartilage. The repairing tissues either form fibrocartilage or go into a hypertrophic stage, both of which do not reproduce the equivalent functionality of endogenous hyaline cartilage. One of the reasons for this is inefficient chondrogenesis by endogenous and exogenous MSC. Drugs that promote chondrogenesis could be used to induce self-repair of damaged cartilage as a non-invasive approach alone, or combined with other techniques to greatly assist the therapeutic outcomes. The recent development of human induced pluripotent stem cell (iPSCs), which are able to self-renew and differentiate into multiple cell types, provides a potentially valuable cell resource for drug screening in a “more relevant” cell type. Here we report a screening platform using human iPSCs in a multi-well plate format to identify compounds that could promote chondrogenesis.

Keywords: hESC, hiPSC, chondrogenesis, compound screening platform

References

  1. Aasen T., Raya A., Barrero M.J., Garreta E., Consiglio A., Gonzalez F., Vassena R., Bilic J., Pekarik V., Tiscornia G., et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotech. 2008;26:1276–1284. doi: 10.1038/nbt.1503. [DOI] [PubMed] [Google Scholar]
  2. Allendorph G.P., Read J.D., Kawakami Y., Kelber J.A., Isaacs M.J., Choe S. Designer TGFβ superfamily ligands with diversified functionality. PLoS ONE. 2011;6:e26402. doi: 10.1371/journal.pone.0026402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bulman, S.E., Barron, V., Coleman, C.M., and Barry, F. (2012). Enhancing the mesenchymal stem cell therapeutic response: cell localization and support for cartilage repair. Tissue Eng Part B Rev. (In Press). [DOI] [PubMed]
  4. Chanda D., Kumar S., Ponnazhagan S. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. Journal of Cell Biochem. 2010;111:249–257. doi: 10.1002/jcb.22701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dowthwaite G.P., Bishop J.C., Redman S.N., Khan I.M., Rooney P., Evans D.J.R., Haughton L., Bayram Z., Boyer S., Thomson B., et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci. 2004;117:889–897. doi: 10.1242/jcs.00912. [DOI] [PubMed] [Google Scholar]
  6. Eiges R., Schuldiner M., Drukker M., Yanuka O., Itskovitz-Eldor J., Benvenisty N. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol. 2001;11:514–518. doi: 10.1016/S0960-9822(01)00144-0. [DOI] [PubMed] [Google Scholar]
  7. Ellis J., Bhatia M. iPSC technology: platform for drug discovery. Clin Pharmacol Ther. 2011;89:639–641. doi: 10.1038/clpt.2011.22. [DOI] [PubMed] [Google Scholar]
  8. Falanga V., Iwamoto S., Chartier M., Yufit T., Butmarc J., kouttab N., Shrayer D., Carson P. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13:1299–1312. doi: 10.1089/ten.2006.0278. [DOI] [PubMed] [Google Scholar]
  9. Francis-West P.H., Abdelfattah A., Chen P., Allen C., Parish J., Ladher R., Allen S., MacPherson S., Luyten F.P., Archer C.W. Mechanisms of GDF-5 action during skeletal development. Development. 1999;126:1305–1315. doi: 10.1242/dev.126.6.1305. [DOI] [PubMed] [Google Scholar]
  10. Goldring M.B., Goldring S.R. Osteoarthritis. J Cell Physiol. 2007;213:626–634. doi: 10.1002/jcp.21258. [DOI] [PubMed] [Google Scholar]
  11. Huang A., Motlekar N., Stein A., Diamond S., Shore E., Mauck R. High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Ann Biomed Eng. 2008;36:1909–1921. doi: 10.1007/s10439-008-9562-4. [DOI] [PubMed] [Google Scholar]
  12. Inoue H., Yamanaka S. The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther. 2011;89:655–661. doi: 10.1038/clpt.2011.38. [DOI] [PubMed] [Google Scholar]
  13. Jiang T.X., Yi J.R., Ying S.Y., Chuong C.M. Activin enhances chondrogenesis of limb bud cells: stimulation of precartilaginous mesenchymal condensations and expression of NCAM. Dev Biol. 1993;155:545–557. doi: 10.1006/dbio.1993.1051. [DOI] [PubMed] [Google Scholar]
  14. Johnson K., Zhu S., Tremblay M.S., Payette J.N., Wang J., Bouchez L.C., Meeusen S., Althage A., Cho C.Y., Wu X., et al. A stem cell-based approach to cartilage repair. Science. 2012;336:717–721. doi: 10.1126/science.1215157. [DOI] [PubMed] [Google Scholar]
  15. Koay E.J., Hoben G.M.B., Athanasiou K.A. Tissue engineering with chondrogenically differentiated human embryonic stem cells. Stem Cells. 2007;25:2183–2190. doi: 10.1634/stemcells.2007-0105. [DOI] [PubMed] [Google Scholar]
  16. Koelling S., Kruegel J., Irmer M., Path J.R., Sadowski B., Miro X., Miosge N. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell. 2009;4:324–335. doi: 10.1016/j.stem.2009.01.015. [DOI] [PubMed] [Google Scholar]
  17. Kuettner K.E. Biochemistry of articular cartilage in health and disease. Clin Biochem. 1992;25:155–163. doi: 10.1016/0009-9120(92)90224-G. [DOI] [PubMed] [Google Scholar]
  18. Laird P.W., Zijderveld A., Linders K., Rudnicki M.A., Rudolf J., Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 1991;19:4293. doi: 10.1093/nar/19.15.4293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liew C.G., Draper J.S., Walsh J., Moore H., Andrews P.W. Transient and stable transgene expression in human embryonic stem cells. Stem cells. 2007;25:1521–1528. doi: 10.1634/stemcells.2006-0634. [DOI] [PubMed] [Google Scholar]
  20. Ludwig T.E., Bergendahl V., Levenstein M.E., Yu J., Probasco M.D., Thomson J.A. Feeder-independent culture of human embryonic stem cells. Nat Meth. 2006;3:637–646. doi: 10.1038/nmeth902. [DOI] [PubMed] [Google Scholar]
  21. Lohmander L.S., Roos E.M. Clinical update: treating osteoarthritis. The Lancet. 2007;370:2082–2084. doi: 10.1016/S0140-6736(07)61879-0. [DOI] [PubMed] [Google Scholar]
  22. MacArthur C.C., Xue h., Hoof D.V., Lieu P.T., Dudas M., Fontes A., Swistowski A., Touboul T., Seerke R., Laurent L.C., et al. Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev. 2012;21:191–205. doi: 10.1089/scd.2011.0163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Majumdar M.K., Wang E., Morris E.A. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol. 2001;189:275–284. doi: 10.1002/jcp.10025. [DOI] [PubMed] [Google Scholar]
  24. Oldershaw R.A., Baxter M.A., Lowe E.T., Bates N., Grady L.M., Soncin F., Brison D.R., Hardingham T.E., Kimber S.J. Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotech. 2010;28:1187–1194. doi: 10.1038/nbt.1683. [DOI] [PubMed] [Google Scholar]
  25. Oreffo R., Cooper C., Mason C., Clements M. Mesenchymal stem cells. Stem Cell Rev Rep. 2005;1:169–178. doi: 10.1385/SCR:1:2:169. [DOI] [PubMed] [Google Scholar]
  26. Pridie K.H. The development and nature of osteroarthritis of the hip joint. Rheumatism. 1955;11:2–7. [PubMed] [Google Scholar]
  27. Sastry L., Johnson T. J., Hobson M. B. S., Hobson K. C. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther. 2002;9:1155–1162. doi: 10.1038/sj.gt.3301731. [DOI] [PubMed] [Google Scholar]
  28. Siddappa R., Licht R., van Blitterswijk C., de Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res. 2007;25:1029–1041. doi: 10.1002/jor.20402. [DOI] [PubMed] [Google Scholar]
  29. Smith G.D., Knutsen G., Richardson J.B. A clinical review of cartilage repair techniques. J Bone Joint Surg Br. 2005;87:445–449. doi: 10.1302/0301-620X.87B4.15971. [DOI] [PubMed] [Google Scholar]
  30. Steinwaerder D.S., Lieber A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther. 2000;7:556–567. doi: 10.1038/sj.gt.3301139. [DOI] [PubMed] [Google Scholar]
  31. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. doi: 10.1016/j.cell.2007.11.019. [DOI] [PubMed] [Google Scholar]
  32. Toh W.S., Yang Z., Liu H., Heng B.C., Lee E.H., Cao T. Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. Stem Cells. 2007;25:950–960. doi: 10.1634/stemcells.2006-0326. [DOI] [PubMed] [Google Scholar]
  33. William R.J., Harnly H.W. Microfrature: indications, technique, and results. Instructional Course Lectures. 2007;56:419–428. [PubMed] [Google Scholar]
  34. Woolf, A.D., and Pfleger, B. (2003). Burden of major musculoskeletal conditions. Bulletin WHO, 646–656. [PMC free article] [PubMed]
  35. Yang H.S., La W.G., Bhang S.H., Kim H.J., Im G.I., Lee H., Park J.H., Kim B.S. Hyaline cartilage regeneration by combined therapy of microfracture and long-term bone morphogenetic protein-2 delivery. Tissue Eng Part A. 2011;17:1809–1818. doi: 10.1089/ten.tea.2010.0540. [DOI] [PubMed] [Google Scholar]
  36. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920. doi: 10.1126/science.1151526. [DOI] [PubMed] [Google Scholar]
  37. Zhou G., Lefebvre V., Zhang Z., Eberspaecher H., de Crombrugghe B. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem. 1998;273:14989–14997. doi: 10.1074/jbc.273.24.14989. [DOI] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES